OPEN ACCESS

PEER-REVIEWED

Original Study

| Published: May 25, 2023

Overview of Cognition and Neurotransmitters in Schizophrenia

Kavya Kadia

High School Student at Udgam School for Children, Ahmedabad, GJ, India Google Scholar More about the auther

, Michael Kelberman

PhD Scholar, Department of Neuroscience, Emory University, Atlanta, GA Google Scholar More about the auther

, Dr. Dhruv Thakkar

Private Practitioner Psychiatrist in India. Google Scholar More about the auther

DIP: 18.01.133.20231102

DOI: 10.25215/1102.133

ABSTRACT

Schizophrenia is a complex mental disorder characterized by a wide range of symptoms, including psychosis, hallucinations, delusions, and cognitive deficits. While much research has focused on the positive and negative symptoms of schizophrenia, such as hallucinations and lack of motivation, cognitive deficits are also prominent features of the disorder but have been understudied. In this article, we discuss cognition in schizophrenia, including the maintenance of cognitive function and the deficits that are commonly observed. We also review typical treatments for schizophrenia and how they target neurotransmitter dysfunction in the brain. Despite the availability of antipsychotic medications that primarily target positive symptoms, current treatments have limited efficacy in improving cognitive deficits in schizophrenia. We highlight the need for further research and development of novel treatments that specifically target cognitive deficits in schizophrenia to improve the overall functioning and quality of life for individuals with this debilitating disorder.

Download Full Text
Responding Author Information

Kavya Kadia @ kavyakadia26@gmail.com

Find On

Article Overview

ISSN 2348-5396

ISSN 2349-3429

18.01.133.20231102

10.25215/1102.133

Download: 10

View: 335

Published in   Volume 11, Issue 2, April-June, 2023